健之佳涨2.04%，成交额1823.58万元，主力资金净流入114.84万元

Core Viewpoint - The stock price of Jianzhijia has shown a slight increase of 2.04% on November 26, 2023, with a current price of 20.52 CNY per share, despite a year-to-date decline of 6.79% [1] Company Overview - Jianzhijia Pharmaceutical Chain Group Co., Ltd. is located in Kunming, Yunnan Province, and was established on September 27, 2004. The company was listed on December 1, 2020. Its main business involves the retail of health products, including pharmaceuticals, health foods, personal care products, and daily consumables [1] - The revenue composition of Jianzhijia includes: prescription and non-prescription drugs (72.60%), with non-prescription drugs at 39.64% and prescription drugs at 32.96%. Other segments include medical devices (7.44%), other (5.52%), convenience products (5.05%), health foods (4.84%), traditional Chinese medicine (3.28%), personal care products (1.18%), and health check services (0.09%) [1] Financial Performance - For the period from January to September 2025, Jianzhijia reported a revenue of 6.549 billion CNY, a year-on-year decrease of 2.77%. The net profit attributable to the parent company was 101 million CNY, reflecting a slight decrease of 0.22% year-on-year [2] - Since its A-share listing, Jianzhijia has distributed a total of 715 million CNY in dividends, with 473 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, Jianzhijia had 15,100 shareholders, a slight decrease of 0.04% from the previous period. The average circulating shares per person increased by 0.04% to 10,240 shares [2] - Among the top ten circulating shareholders, Rongtong Health Industry Flexible Allocation Mixed A/B holds 7.1 million shares, remaining unchanged from the previous period. Meanwhile, Guangfa Innovation Upgrade Mixed has exited the top ten list [3]